Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.
about
Timing of therapies for Down syndrome: the sooner, the betterQuantitative magnetic resonance imaging of the fetal brain in utero: Methods and applications.Rapid initiation of fetal therapy services with a system of learner-centred training under proctorship: the National University Hospital (Singapore) experience.The amniotic fluid transcriptome as a guide to understanding fetal disease.An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society.What does next-generation sequencing mean for prenatal diagnosis?Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.Combined detection of α-fetoprotein and free β-human chorionic gonadotropin in screening for trisomy 21 and management of cases in the moderate risk value range.Down syndrome: Past concerns and future promises.Chromosome Screening Using Noninvasive Prenatal Testing Beyond Trisomy-21: What to Screen for and Why It Matters.Fetal therapy for Down syndrome: an ethical exploration.Noninvasive prenatal testing: the paradigm is shifting rapidly.The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.In case you missed it: thePrenatal Diagnosissection editors bring you the most significant advances of 2013
P2860
Q26779297-7EC83F2A-B2D9-4862-98B8-758B58ADF916Q27026765-B44F66D4-EA7A-465D-BA86-672AFEB33003Q33809806-FC5DF6C8-6A47-4FF0-A025-F9E0E71FA27DQ35245269-193718FE-016E-443F-9207-5A61BEDFB2CCQ37228171-4D293ABB-074B-4289-8E07-6A6D5532769CQ37415153-DB1AADFA-B57B-4948-9987-9F342D206E22Q38209384-11F3AFE8-9DAD-457A-92AA-F2BE654475D1Q38973876-331690FA-256B-4B46-9583-969D8D0A039AQ41542227-AAC363FE-453C-4073-9717-4D4FFDC3E906Q43494523-2E7A3338-325D-43BC-9FC6-0ED7DCC1B84BQ47751664-35274493-AD1C-45DB-8012-00E2442B44AFQ48126029-6ED08C73-B527-4D88-B5CA-742F6264ADBFQ48240788-80609B22-6D6A-42D4-BBB1-939F482CAC04Q54988096-4846CCEB-FAB7-401D-A188-47446431F255Q57839579-564E2946-9183-44D0-AA45-ED5A66448C05
P2860
Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@ast
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@en
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@nl
type
label
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@ast
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@en
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@nl
prefLabel
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@ast
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@en
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@nl
P2860
P356
P1433
P1476
Noninvasive prenatal testing c ...... al treatment of Down syndrome.
@en
P2093
Diana W Bianchi
Faycal Guedj
P2860
P304
P356
10.1002/PD.4134
P577
2013-06-01T00:00:00Z